His latest project, Druglike, most definitely isn’t in the pharmaceutical business, from which he’s been banned

Martin Shkreli, released from prison in May after serving much of his seven-year prison sentence for securities fraud, on Monday announced Druglike, described as “a Web3 drug discovery software platform.”…